Bioventus (BVS) Cash from Operations (QoQ) (2020 - 2026)
Bioventus (BVS) Cash from Operations (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Bioventus | 967.47 Mn | 938.02 Mn | 105.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 122.44% |
| Mar 28, 2026 | -76.47% |
| Dec 31, 2025 | 26.15% |
| Sep 27, 2025 | 16.04% |
| Jun 28, 2025 | 234.18% |
| Mar 29, 2025 | -200.05% |
| Dec 31, 2024 | 87.30% |
| Sep 28, 2024 | -31.96% |
| Jun 29, 2024 | 352.49% |
| Mar 30, 2024 | -157.89% |
| Dec 31, 2023 | 198.95% |
| Sep 30, 2023 | -197.12% |
| Jul 1, 2023 | 131.70% |
| Apr 1, 2023 | 6.25% |
| Dec 31, 2022 | 2,675.32% |
| Oct 1, 2022 | -94.62% |
| Jul 2, 2022 | 113.98% |
| Apr 2, 2022 | -260.24% |
| Dec 31, 2021 | 23.90% |
| Oct 2, 2021 | -38.91% |